Functional neurological disorders after COVID-19 and SARS-CoV-2 vaccines: a national multicentre observational study

被引:8
|
作者
Alonso-Canovas, Araceli [1 ,2 ]
Kurtis, Monica M. [3 ]
Gomez-Mayordomo, Victor [4 ]
Macias-Garcia, Daniel [5 ,6 ]
Viedma, Alvaro Gutierrez [7 ]
Rezola, Elisabet Mondragon [8 ]
Pagonabarraga, Javier [9 ,10 ]
Orgaz, Lidia Aranzabal [11 ]
Masjuan, Jaime [1 ,2 ]
Martinez-Castrillo, Juan Carlos [1 ,2 ]
Parees, Isabel [2 ,3 ]
机构
[1] Univ Alcala, Med Dept, Madrid, Spain
[2] Hosp Univ Ramon & Cajal, Neurol Dept, Movement Disorders Unit, IRYCIS, Madrid, Spain
[3] Hosp Ruber Int, Neurol Dept, Funct Movement Disorders Unit, Madrid, Spain
[4] Vithas Hosp Grp, Inst Neurosci, Dept Neurol, Madrid, Spain
[5] CIBERNED, Madrid, Spain
[6] Univ Seville, Hosp Univ Virgen Rocio, Neurol & Neurophysiol Dept, Movement Disorders Unit,Inst Biomed Sevilla,CSIC, Seville, Spain
[7] Hosp Univ Fdn Jimenez Diaz, Neurol Dept, Funct Disorders Unit, Madrid, Spain
[8] Hosp Univ Donostia, Dept Neurol, Inst Invest Sanitaria Biodonostia, San Sebastian, Spain
[9] Univ Autonoma Barcelona UAB, Hosp St Pau, Neurol Dept, Movement Disorders Unit, Barcelona, Spain
[10] St Pau Inst Biomed Res IIB St Pau, Barcelona, Spain
[11] Hosp Univ Ramon & Cajal, Internal Med Dept, Madrid, Spain
来源
关键词
COVID-19; CONVERSION DISORDER; FUNCTIONAL NEUROLOGICAL DISORDER;
D O I
10.1136/jnnp-2022-330885
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:776 / 777
页数:2
相关论文
共 50 条
  • [31] A comprehensive review on various aspects of SARS-CoV-2 (COVID-19) vaccines
    Pordanjani, Sajjad
    Pordanjani, Ali
    Askarpour, Hasan
    Arjmand, Mehrdad
    Babakhanian, Masoudeh
    Amiri, Masoud
    Mazaheri, Elaheh
    INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 2022, 13 (01) : 151
  • [32] Recipients of COVID-19 vaccines face challenges of SARS-CoV-2 variants
    Li, Tianhong
    Luo, Kathy Qian
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2022, 18 (11): : 4642 - 4647
  • [33] SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisis
    Tsvetelina Velikova
    Tsvetoslav Georgiev
    Rheumatology International, 2021, 41 : 509 - 518
  • [34] An Overview of Vaccines against SARS-CoV-2 in the COVID-19 Pandemic Era
    Pascual-Iglesias, Alejandro
    Canton, Javier
    Ortega-Prieto, Ana Maria
    Jimenez-Guardeno, Jose M.
    Regla-Nava, Jose Angel
    PATHOGENS, 2021, 10 (08):
  • [35] SARS-CoV-2 vaccines for all but a single dose for COVID-19 survivors
    Frieman, Matthew
    Harris, Anthony D.
    Herati, Ramin Sedaghat
    Krammer, Florian
    Mantovani, Alberto
    Rescigno, Maria
    Sajadi, Mohammad M.
    Simon, Viviana
    EBIOMEDICINE, 2021, 68
  • [36] Recipients of COVID-19 vaccines face challenges of SARS-CoV-2 variants
    Li, Tianhong
    Luo, Kathy Qian
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2022, 18 (12): : 4642 - 4647
  • [37] SARS-CoV-2 Proteins: Are They Useful as Targets for COVID-19 Drugs and Vaccines?
    Mohammed, Mohammed Elimam Ahamed
    CURRENT MOLECULAR MEDICINE, 2022, 22 (01) : 50 - 66
  • [38] COVID-19 vaccines: Keeping pace with SARS-CoV-2 variants Comment
    Cevik, Muge
    Grubaugh, Nathan D.
    Iwasaki, Akiko
    Openshaw, Peter
    CELL, 2021, 184 (20) : 5077 - 5081
  • [39] Progress and Pitfalls in the Quest for Effective SARS-CoV-2 (COVID-19) Vaccines
    Flanagan, Katie L.
    Best, Emma
    Crawford, Nigel W.
    Giles, Michelle
    Koirala, Archana
    Macartney, Kristine
    Russell, Fiona
    Teh, Benjamin W.
    Wen, Sophie C. H.
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [40] β-Glucans Could Be Adjuvants for SARS-CoV-2 Virus Vaccines (COVID-19)
    Cordova-Martinez, Alfredo
    Caballero-Garcia, Alberto
    Roche, Enrique
    Noriega, David C.
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (23)